Nicolás Vazquez

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

Manel Sabaté, Ángel Cequier, Andrés Íñiguez et al. · The Lancet · 2012 · 457 citations · Full text

Medicine, Cardiology, Surgery +14

Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial

Francisco Fernández‐Avilés, Joaquín Alonso, Alfonso Castro‐Beiras et al. · The Lancet · 2004 · 416 citations

Medicine, Cardiology, Internal Medicine +14

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

Pieter C. Smits, Sjoerd H. Hofma, Mario Togni et al. · The Lancet · 2013 · 290 citations

Medicine, Cardiology, Surgery +10

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

Manel Sabaté, Salvatore Brugaletta, Ángel Cequier et al. · The Lancet · 2015 · 195 citations · Full text

Medicine, Cardiology, Surgery +17

Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Georgios J. Vlachojannis, Pieter C. Smits, Sjoerd H. Hofma et al. · JACC: Cardiovascular Interventions · 2017 · 103 citations

Medicine, Cardiology, Biomaterials +11